An Isotoxic Planning Comparison Study for Stage II-III Non-small Cell Lung Cancer: Is Intensity-modulated Radiotherapy the Answer?

Authors
Warren, Mark
Webster, G
Ryder, W David J
Rowbottom, Carl G
Faivre-Finn, Corinne
Affiliation
Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK
Issue Date
2014-05-01

Metadata
Show full item record
Abstract
Recent clinical series suggest that treating patients with isotoxic twice-daily radiotherapy may be beneficial. This dosimetric planning study compared the use of intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3DRT) to deliver isotoxic treatment for non-small cell lung cancer (NSCLC) patients.
Citation
An Isotoxic Planning Comparison Study for Stage II-III Non-small Cell Lung Cancer: Is Intensity-modulated Radiotherapy the Answer? 2014: Clin Oncol
Journal
Clinical Oncology
URI
http://hdl.handle.net/10541/317652
DOI
10.1016/j.clon.2014.03.011
PubMed ID
24793504
Type
Article
Language
en
ISSN
1433-2981
Collections